PCSK9 Inhibitors

What are PCSK9 Inhibitors? The Food and Drug Administration recently approved two products in a new class of cholesterol-lowering drugs known as PCSK9 Inhibitors. This class of drugs reduces the amount of low-density lipoprotein cholesterol (LDL-C), or “bad... read more

DRUG NEWS: Daraprim®

In the News: Daraprim® Turing Pharmaceuticals, the company who recently bought the rights to Daraprim® (pyrimethamine), implemented a massive price increase for the drug this past month, claiming that it had been severely under-priced for years. Costs in the U.S. for... read more